DDOG vs RPRX · P/E 292, rev $2.13B vs P/E 15, rev $1.30B
Datadog Inc (DDOG) versus Royalty Pharma Plc (RPRX) — a side-by-side from cached financials, not a winner call.
Datadog Inc (DDOG) is a software - application company listed on US.
Royalty Pharma Plc (RPRX) is a biotechnology company listed on US.
Latest reported DDOG revenue for 2026-06-30 was $2.13B. Net income was $97.1M. DDOG currently screens at market cap $47.44B and trailing P/E 292.3.
Latest reported RPRX revenue for 2026-06-30 was $1.30B. Net income was $312.6M. RPRX currently screens at market cap $20.45B and trailing P/E 14.8.
DDOG currently screens at market cap $47.44B and trailing P/E 292.3. RPRX currently screens at market cap $20.45B and trailing P/E 14.8.
Not investment advice. Open the DDOG and RPRX stock pages for the full models.
Not investment advice.